Articles

BOSTON--(BUSINESS WIRE)--T1D Exchange today announced that it will share data from ten abstracts, including six late breaking, focused on quality improvement, population health and real-world evidence and outcomes of people living with type 1 diabetes (T1D) at the American Diabetes Association (ADA) 80th Scientific Virtual Sessions. Two posters from the organization’s Quality Improvement Collaborative were recognized by healthcare information firm Close Concerns in its list of Top 50 Most Notable Posters.

We're going to take the opportunity to share out some critical resources each week that may help people get through this challenging coronavirus pandemic with the help of partners and experts.

Preliminary results of our population health surveillance study, “Type 1 Diabetes and COVID-19: Preliminary Findings from a Multi-Center Surveillance Study in the United States,” were recently published in Diabetes Care, the peer-reviewed medical journal of the American Diabetes Association. The study focuses on individuals with type 1 diabetes (T1D) who are suspected or confirmed to have contracted Coronavirus Disease 2019 (COVID-19). This is the first U.S. based, multi-center study to examine patient characteristics and adverse outcomes among individuals with confirmed or suspected COVID-19.

We're going to take the opportunity to share out some critical resources each week that may help people get through this challenging coronavirus pandemic with the help of partners and experts.

A Message from Our CEO

We are deeply saddened to observe the recent needless loss of innocent life of George Floyd, and the pain it has inflicted on communities throughout our country. While we have recently been focused on the challenges posed by the global COVID-19 pandemic, including its disproportionate impact on people of color, this recent tragedy has only exacerbated these challenges.

We're going to take the opportunity to share out some critical resources each week that may help people get through this challenging coronavirus pandemic with the help of partners and experts.

A new study recently released by the National Health Service in the United Kingdom showed that people with type 1 diabetes are significantly more likely to die in the hospital setting from COVID-19 than people living with type 2 diabetes.

We're going to take the opportunity to share out some critical resources each week that may help people get through this challenging coronavirus pandemic with the help of partners and experts.

Individuals with diabetes type 1 are impacted by significant injustices, geographical disparities, and inequities. These are difficult truths – but not ones we have to be resigned to. Check out this fascinating dive into the potential of virtual clinics, telemedicine, and innovative nonprofit strategies from one of our partners at The Helmsley Charitable Trust.

Your Daily News Roundup Everything you need to know this week about type 1 diabetes and coronavirus updates, in one easy-to-read place.  Researchers, advocates, clinicians, and organizations around the country and across the web have been hard at work, creating resources for people living with T1D to better handle the ongoing COVID-19 coronavirus pandemic. We’re …